Financial Engines Advisors
GTHX

Financial Engines Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Financial Engines Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,333
Closed -$37.6K – 366
2023
Q4 		$37.6K Buy
+12,333
New +$23.2K ﹤0.01% 316
2023
Q3 		– Sell
-15,107
Closed -$37.6K – 304
2023
Q2 		$37.6K Buy
+15,107
New +$41.3K ﹤0.01% 285

Other funds holding GTHX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Financial Engines Advisors's GTHX Position: Q1 2024 in Review

Financial Engines Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 12,333 shares — an estimated $37.6K sold.

Financial Engines Advisors first reported a position in GTHX in Q2 2023 and held it in 2 quarters. The position peaked at $37.6K in Q4 2023. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.

  • Financial Engines Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Financial Engines Advisors sold 12,333 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $37.6K.
  • Financial Engines Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Financial Engines Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $37.6K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Financial Engines Advisors's 13F filing for Q1 2024, filed 13 May 2024.